942308-06-7 Usage
Uses
Used in Pharmaceutical Compound Preparation:
3-(Methoxymethyl)azetidine hydrochloride is used as a reagent in the synthesis of various pharmaceutical compounds, leveraging its unique cyclic structure and reactivity to facilitate the creation of new and effective medications.
Used in Chemical Synthesis as a Building Block:
In the field of chemical synthesis, 3-(Methoxymethyl)azetidine hydrochloride serves as a valuable building block, contributing to the development of complex organic molecules and compounds with specific applications in various industries.
Used in Medicinal Chemistry and Drug Development:
3-(Methoxymethyl)azetidine hydrochloride is utilized in medicinal chemistry and drug development for its potential to contribute to the discovery and creation of novel therapeutic agents, thanks to its distinctive structural features and synthetic utility.
Used in Research and Development:
3-(Methoxymethyl)azetidine hydrochloride is also used in research and development settings to explore its properties and potential applications, furthering the understanding of its role in chemical and pharmaceutical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 942308-06-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,2,3,0 and 8 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 942308-06:
(8*9)+(7*4)+(6*2)+(5*3)+(4*0)+(3*8)+(2*0)+(1*6)=157
157 % 10 = 7
So 942308-06-7 is a valid CAS Registry Number.
InChI:InChI=1/C5H11NO.ClH/c1-7-4-5-2-6-3-5;/h5-6H,2-4H2,1H3;1H
942308-06-7Relevant academic research and scientific papers
VLA-4 INHIBITORY DRUG
-
Page/Page column 90, (2008/12/08)
There is provided a VLA-4 inhibitory drug having good oral absorbability and exhibiting sufficient anti-inflammatory effects when administered orally. A compound represented by the following formula (I): wherein R1 represents a hydrogen atom or a C1-8 alkyl group; R2 represents a hydrogen atom, a halogen atom, a C1-8 alkoxy group, orabenzyloxygroupwhichmaybe substituted; Q represents a monocyclic or bicyclic nitrogen-containing heterocyclic group which may be substituted, and has a nitrogen atom as the bonding site; Y represents an oxygen atom or CH2; W represents a bicyclic aromatic hydrocarbon ring group which may be substituted, or a bicyclic aromatic heterocyclic group whichmaybe substituted; R3a, R3b and R3c each independently represent a hydrogen atom, a halogen atom, a C1-8 alkoxy group or a C1-8 alkyl group; and A1 represents a nitrogen atom or C-R3d (wherein R3d represents a hydrogen atom, a halogen atom, a C1-8 alkoxy group or a C1-8 alkyl group), or a salt thereof, or a VLA-4 inhibitory drug comprising the compound or the salt as an active ingredient.
